Video
With a shift from intravenous to self-administered medication, specialty pharmacists are key in patient education.
Brandon Shank, PharmD, MPH, BCOP, Clinical Pharmacy Specialist, explains why specialty pharmacists must understand the logitistics, toxicities, and the reimbursement payment models of the new, self-administered treatments for cancer. It is important that specialty pharmacists understand these treatments in order to provide proper patient education.